AKT1 and neoplasm: Immunohistochemistry results demonstrated that, in the tumor tissue of the TRAF6 shRNA group, Akt phosphorylation was substantially decreased, and the expression of hexokinase-2 was also dramatically reduced, which was in accordance with the in vitro results.